VIR-3434

· Vir Biotechnology, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VIR-3434, covering 2024-10-08 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection [Phase 2]